Hidradenitis Suppurativa Responds Quickly to Novel BTK Inhibitor

At least 50% reduction in abscess, nodule count at 16 weeks for more than 70% of patients

Related Keywords

United States ,Boston ,Massachusetts ,American ,Alexab Kimball ,Charles Bankhead ,American Academy Of Dermatology ,Beth Israel Deaconess Medical Center ,American Academy ,Hidradenitis Suppurativa Clinical Response ,Medpage Today ,